Real-time enrollment status for this relapsed large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:20 PM UTC
| NCT Number | NCT06811272 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Large B-cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | February 24, 2026 (Feb 24, 2026) |
As of July 13, 2026: Clinical trial NCT06811272 is currently recruiting participants. This clinical trial study for relapsed large b-cell lymphoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06811272 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06811272 was last updated Feb 24, 2026 (February 24, 2026). HelloStudys verifies this status automatically.